Article
A Targeted, Low-Throughput Compound Screen in a <i>Drosophila</i> Model of…
eNeuro · 2023 · RA. Baines, A. Dyson, DG. Evans, S. Garg, M. Ryan
Key facts
| Title | A Targeted, Low-Throughput Compound Screen in a <i>Drosophila</i> Model of Neurofibromatosis Type 1 Identifies Simvastatin and BMS-204352 as Potential Therapies for Autism Spectrum Disorder (ASD). |
|---|---|
| First author | RA. Baines, A. Dyson, DG. Evans, S. Garg, M. Ryan |
| Journal | eNeuro |
| Published | May 16, 2023 |
| DOI | 10.1523/eneuro.0461-22.2023 |
| PubMed ID | 37185294 |
| PMC ID | PMC10198605 |
| Devices mentioned | 204352 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1